Format

Send to

Choose Destination
Rheumatology (Oxford). 2013 Oct;52(10):1898-904. doi: 10.1093/rheumatology/ket238. Epub 2013 Jul 19.

Impaired quality of life, disability and mental health in Takayasu's arteritis.

Author information

1
Arpaemini Cad. Tatlıpınar Cad., No: 6/2 - 34270, Fatih/Istanbul, Turkey. dr.yilmazneslihan@gmail.com.

Abstract

OBJECTIVE:

Patient-reported outcomes (PROs) are increasingly accepted to be among the major tools for outcome assessment in rheumatic disorders. In this study we aimed to assess quality of life (QoL), disability, anxiety and depression in patients with Takayasu's arteritis (TAK).

METHODS:

Patients followed with the diagnosis of TAK (n = 165) and healthy controls (HCs) (n = 109) were enrolled to the study. The 36-item Short Form Health Survey (SF-36) and hospital anxiety and depression scales (HADS) were used to assess QoL and mental status together with HAQ for disability.

RESULTS:

In SF-36 subscale assessment, all items were observed to be statistically lower in TAK patients; similarly HAQ scores were also higher (P < 0.001) in this group. In mental assessment, anxiety was found to be more common in TAK patients [90 (54.5%) vs 38 (34.9%), P = 0.001]. Depression also tended to be higher in TAK patients [70 (66.7%) vs 35 (33.3%)], without reaching significance (P = 0.086). Most of the SF-36 subgroup parameters were lower in TAK patients with active disease. Patients having anxiety and depression or with high HAQ scores reported worse SF-36 scores. In multivariate analysis, HADS-A, HADS-D and HAQ were associated with most SF-36 subscales.

CONCLUSION:

PROs demonstrate that not only general health but also physical and social functioning with physical role limitations and mental health parameters were impaired in TAK. Our results, especially in active disease, suggest that PROs such as SF-36 can be core domains of disease assessment in TAK, similar to ANCA-associated vasculitides.

KEYWORDS:

Takayasu’s arteritis; function; mental status; quality of life

PMID:
23873821
DOI:
10.1093/rheumatology/ket238
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center